Integrin beta-2 (ITGB2 or CD18) Antibody

Scientific Overview

When you need to analyze Integrin beta-2 with attention to cellular organization, this antibody provides a focused option. Integrin beta-2 is an adhesion-related target that can shift with substrate composition and mechanical cues. Its behavior can reflect changes in differentiation state, stress, or remodeling of cellular architecture.

In some datasets and protocols, it is referenced by the gene symbol CD18.

Research Relevance

Comparative experiments can separate expression differences from changes in adhesion structure abundance. Because regulation can be multi-layered, combining abundance and localization information can sharpen conclusions.

When cell-state transitions occur, this target may change alongside partners in the same compartment or pathway neighborhood.

When building a narrative around the target, it helps to track:

• effects of adhesion inhibitors or matrix composition
• focal adhesion versus diffuse membrane distribution
• co-variation with cytoskeletal and scaffold partners

Application-Specific Context

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior. Think about how preparation affects epitope accessibility, and interpret patterns alongside morphology and compartment markers as needed.

When interpreting Integrin beta-2, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

When interpreting Integrin beta-2, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

Use the regular format variant when your project demands Integrin beta-2 readouts that respect preparation constraints.